Read and React
- MVD and primary PCI: which strategy?
- 'The Great Debate' - Dual antiplatelet therapy - Which drug? For which patient? For which stent? For how long?
- 'The Great Debate' - Diffuse Coronary artery disease - Available options? New strategies on the Horizon? How to best optimise the options?
- Is what you see really what you get?
- FFR assessment of coronary stenoses in series
Quick links
- Home
- |
- Table of content
Table of content
-
Editorials
- TAVI patient selection and access route: what have we learned?
- TAVI: how do we decide valve size and type
- TAVI and stroke
- Specialised imaging modalities: are they needed?
- Health economics: can the world "afford" transcatheter valvular interventions?
- Innovative surgery to the aortic valve
- Surgical and transcatheter interventions to the mitral valve
- Technological progress and newer generation TAVI devices
- PCR London Valves 2012 represents the most important European congress...
- GE Healthcare has a strong history of providing educational activities to support physicians in numerous medical fields.
- The development of "future" technologies is a continuous process
- Introducing the next Generation transcatheter valves and delivery systems!
- St. Jude Medical is pleased to return to PCR London Valves...
